Table with 5 columns and 3 rows. Currently displaying rows 1 to 3.
Acadia’s Daybue (trofinetide)Phase III LAVENDAR (NCT04181723)
187 patients
12 weeks
Met co-primary endpoints of RSBQ and CGI-I
Anavex’s ANAVEX2-73Phase III AVATAR (NCT03941444)
33 patients
7 weeks
Met primary endpoint of RSBQ
Anavex’s ANAVEX2-73Phase II/III EXCELLENCE (NCT04304482)
92 patients
12 weeks
Ongoing (primary endpoint of RSBQ)
GlobalData